News & Media

Get news alerts by email

News Releases
Dec 072017

Cardinal Health Specialty Solutions today introduced the second edition of Oncology Insights, a research-based report outlining the views of more than 200 U.S. oncologists on the latest medical...

Nov 302017

Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIRâ„¢ drug-eluting stent (DES) for the treatment of patients...

Nov 162017

Cardinal Health (NYSE: CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation's hardest-hit states across Appalachia combat the opioid epidemic. The...

Nov 142017

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma")...

Nov 142017

As an organization that believes cultivating a diverse and inclusive work environment is crucial to corporate success, Cardinal Health earned a perfect score on the 2018 Corporate Equality Index...

See More


Get news alerts by email

Complete the form below to receive e-mail notifications of our news releases. You will receive an email which you must reply to in order to confirm your subscription. You may unsubscribe from our list at anytime.